Kirsten E. Lyke

Co-Director of the Malaria Research Program · University of Maryland (UMB) School of Medicine

Credentials: · · ·

History

Malaria Research Program · University of Maryland (UMB) School of Medicine
Present
University of Maryland (UMB) School of Medicine
2002–Present

The Johns Hopkins University School of Medicine
1998–2002
University of Maryland School of Medicine Center for Vaccine Development
1999–2002
Duke University Medical Center
1992–1995
Universidadé dos Espirito Santos
Until 1995
Hospital Dar es Salaam, Tanzania
Until 1994
Georgetown University School of Medicine
1992
Cornell University College of Arts and Sciences
1988

Immunologic Determinants of Schistosoma-Mediated Resistance to Malaria in Humans
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.1M · University of Maryland Baltimore
2008–2013
Immunologic Interaction of Schistomiasis & Acute Malaria
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $506.5K · University of Maryland Baltimore
2002–2006

A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI
Principal investigator · Terminated · Phase 1
Sanaria Inc.
2022–2023
Combination HTNV and PUUV DNA Vaccine
Principal investigator · Completed · Phase 1
U.S. Army Medical Research and Development Command
2019–2022
Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults
Principal investigator · Completed · Phase 3
Protein Sciences Corporation
2006–2007
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2021–2023